5 Results

People

  1. Basu
    Basu
  2. Cheung
    Cheung
  3. Kushner
    Kushner
  4. Modak
    Modak
  5. Roberts
    Roberts
  6. Kramer
    Kramer
  7. Cheung
    Cheung
  8. La Quaglia
    La Quaglia
  9. Wolden
    Wolden
  10. Friedman
    Friedman

Groups

  1. Neuroblastoma Service (5)
  2. Pediatrics, Department of (5)
  3. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (4)
  4. GSK Faculty (4)
  5. Neuro-Oncology Service (4)
  6. Tow Center for Developmental Oncology (TCDO) (4)
  7. General Oncology Service (3)
  8. Survivorship Research (3)
  9. Center for Hematologic Malignancies (2)
  10. Pediatric Leukemia (2)
  1. "unclassified drug"
  2. "Ellen Basu"
Formats
  1. Journal Article (4)
  2. Correspondence (1)
Groups
  1. Neuroblastoma Service (5)
  2. Pediatrics, Department of (5)
  3. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (4)
  4. GSK Faculty (4)
  5. Neuro-Oncology Service (4)
  6. Tow Center for Developmental Oncology (TCDO) (4)

More Groups

People
  1. Ellen Basu (5)
  2. Brian Kushner (4)
  3. Nai-Kong Cheung (4)
  4. Shakeel Modak (4)
  5. Stephen Roberts (4)
  6. Kim Kramer (3)

More People

Years
  1. 2020 (1)
  2. 2018 (1)
  3. 2017 (2)
  4. 2015 (1)
Publications
  1. Cancer (1)
  2. International Journal of Cancer (1)
  3. OncoImmunology (1)
  4. Oncotarget (1)
  5. Pediatric Blood and Cancer (1)
Publishers
  1. Impact Journals (1)
  2. John Wiley & Sons (1)
  3. Landes Bioscience (1)
  4. Wiley Blackwell (1)
  5. Wiley Periodicals, Inc (1)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • An unusual case of opsoclonus-myoclonus-ataxia syndrome associated neuroblastoma: High-risk disease requiring immunotherapy
    Correspondence

    Stiefel, J.; Basu, E.; Meyer, R.; Kaur, G.; Khakoo, Y.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Treatment and outcome of adult-onset neuroblastoma
    Journal Article

    Suzuki, M.; Kushner, B. H.; Kramer, K.; Basu, E. M.; Roberts, S. S.; Hammond, W. J.; LaQuaglia, M. P.; Wolden, S. L.; Cheung, N. K. V.; Modak, S.
    International Journal of Cancer (2018)

    Fulltext@MSK | Save
  • MYCN-amplified stage 2/3 neuroblastoma: Excellent survival in the era of anti-G(D2) immunotherapy
    Journal Article

    Kushner, B. H.; LaQuaglia, M. P.; Modak, S.; Wolden, S. L.; Basu, E. M.; Roberts, S. S.; Kramer, K.; Yataghene, K.; Cheung, I. Y.; Cheung, N. V.
    Oncotarget (2017)

    Fulltext@MSK | Save
  • Phase I trial of anti-GD2 monoclonal antibody hu3F8 plus GM-CSF: Impact of body weight, immunogenicity and anti-GD2 response on pharmacokinetics and survival
    Journal Article

    Cheung, I. Y.; Kushner, B. H.; Modak, S.; Basu, E. M.; Roberts, S. S.; Cheung, N. K. V.
    OncoImmunology (2017)

    Fulltext@MSK | Save
  • Osteochondroma in long-term survivors of high-risk neuroblastoma
    Journal Article

    Kushner, B. H.; Roberts, S. S.; Friedman, D. N.; Kuk, D.; Ostrovnaya, I.; Modak, S.; Kramer, K.; Basu, E. M.; Cheung, N. K. V.
    Cancer (2015)

    Fulltext@MSK | Save